MCLEAN, Va., April 19, 2018 -- Freddie Mac (OTCQB:FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing average mortgage rates jumping across the board.
|
|||||
News Facts
- 30-year fixed-rate mortgage (FRM) averaged 4.47 percent with an average 0.5 point for the week ending April 19, 2018, up from last week when it averaged 4.42 percent. A year ago at this time, the 30-year FRM averaged 3.97 percent.
- 15-year FRM this week averaged 3.94 percent with an average 0.4 point, up from last week when it averaged 3.87 percent. A year ago at this time, the 15-year FRM averaged 3.23 percent.
- 5-year Treasury-indexed hybrid adjustable-rate mortgage (ARM) averaged 3.67 percent this week with an average 0.3 point, up from last week when it averaged 3.61. A year ago at this time, the 5-year ARM averaged 3.10 percent.
Average commitment rates should be reported along with average fees and points to reflect the total upfront cost of obtaining the mortgage. Visit the following link for the Definitions. Borrowers may still pay closing costs which are not included in the survey.
Quote
Attributed to Len Kiefer, Deputy Chief Economist.
“Treasury yields rose ahead of the release of the Fed’s Beige Book and speeches from New York Fed President William Dudley and Fed Governor Randal Quarles. According to the Beige Book, economic activity in March and early April continued to expand at a moderate pace, however there is concern from various industries surrounding tariffs. Following Treasurys, mortgage rates soared. The U.S. weekly average 30-year fixed mortgage rate rose 5 basis points to 4.47 percent in this week’s survey, its highest level since January of 2014 and the largest weekly increase since February of this year.
“It is important to note that the weekly rate we report is an average and the actual rate obtained by a borrower may be different. In our April Insight, we found that by shopping more than one mortgage lender, consumers are more likely to get a better interest rate and save money in both the short and long term. With lower monthly payments and lower fixed fees, the loan will be more affordable and thus safer, and consumers may keep hundreds or thousands of dollars more in their pocket.”
Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters in communities nationwide. We are building a better housing finance system for homebuyers, renters, lenders and taxpayers. Learn more at FreddieMac.com, Twitter @FreddieMac and Freddie Mac’s blog FreddieMac.com/blog.
A photo accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/67fa74a1-6ba4-4f3b-aaca-a675813acbbc
MEDIA CONTACT: Paul Frommelt
703-903-3999
[email protected]


Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Bain Capital Secures RBI Approval to Acquire Up to 41.7% Stake in Manappuram Finance
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 



